Table 5.
Number of patients (%) | Description | Number of patients (%) | |
---|---|---|---|
Duration of signs and symptoms | Less than 1 year Long term** | 6 (19.4) 25 (80.6) | |
Signs and symptoms | |||
Erythema migrans | 5 (16.1) | ||
Asthenia | 31 (100) | Moderate | 10 (32.2) |
Strong | 21 (67.8) | ||
Joint pain (often migrating) | 31 (100) | Moderate | 9 (29) |
Strong | 22 (71) | ||
Neurocognitive disorders | 31 (100) | Loss of concentration, attention, memory and/or speech | |
Sleeping disorders | 31 (100) | ||
Other pains | Myalgia | 25 (80.6) | |
Including muscle cramps | 16 (51.6) | ||
Cephalalgia (strong) | 20 (64.5) | ||
Thermoregulation disorders and associated signs | Chilliness | 18 (58) | |
Hot flushes | 16 (51.6) | ||
Sweats (mainly at night) | 15 (48.4) | ||
Relapsing fever | 11 (35) | ||
Respiratory symptoms | Chest tightness/lack of air | 13 (41.9) | |
Dyspnea | 6 (19.4) | ||
Balance disorders/malaises | Repeated falls | 3 (9.7) | |
Repeated malaises | 2 (6.5) | ||
Visual disturbances | Amputation of the visual field | 1 (3.2) | |
Diplopia | 1 (3.2) | ||
Other neurologic disorders | Parsonage-Turner syndrome | 2 (6.5) | |
Multiple sclerosis | 1 (3.2) | ||
Manic depressive psychosis | 1 (3.2) |
These 31 patients are those, among the 43 patients of the study, who fulfilled with their physician a questionnaire.
For six patients, the duration of signs and symptoms was less than one year, while for 25 patients, average duration of signs and symptoms was 9 years, with a range from 1 to 30 years. Two patients have been sick for almost 30 years, two other patients for at least 20 years, the remaining patients between 1 and 19 years.